Share Price and Basic Stock Data
Last Updated: October 18, 2025, 5:39 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Kanoria Chemicals & Industries Ltd operates in the organic chemicals sector, primarily focusing on alcohol-based products. As of the latest reporting, the company’s stock price stood at ₹80.5, with a market capitalization of ₹354 Cr. The revenue trends over the past quarters reveal fluctuations, with sales recorded at ₹386 Cr in June 2022, peaking at ₹445 Cr in March 2023, before tapering to ₹371 Cr in September 2023. The company reported total sales of ₹1,578 Cr for FY 2023, which marked a rise from ₹1,369 Cr in FY 2022. However, FY 2024 saw a decline in sales to ₹1,477 Cr, indicating potential challenges in maintaining revenue momentum. The operating profit margin (OPM) was low at 4% for FY 2024, reflecting the pressures on profitability amid rising operational costs. The company’s cash conversion cycle stood at 63 days, indicating a reasonable efficiency in managing working capital, but further improvements could enhance liquidity and operational performance.
Profitability and Efficiency Metrics
Profitability metrics for Kanoria Chemicals have shown concerning trends, with a net profit of ₹-108 Cr reported for FY 2025, down from ₹-55 Cr in FY 2024. Operating profit for the recent quarter ending March 2025 was ₹17 Cr, translating to an OPM of 4%, which is below the industry average. The interest coverage ratio (ICR) stood at 1.67x, indicating a limited ability to cover interest expenses with operating profits, which raises concerns about financial stability. Furthermore, return on equity (ROE) was reported at 11.8%, while return on capital employed (ROCE) was significantly lower at 2.33%, underscoring inefficiencies in capital utilization. The company’s earnings per share (EPS) for FY 2025 was recorded at ₹-19.13, reflecting substantial losses and diminishing shareholder value. Given these profitability challenges, the company must explore strategies to improve cost management and enhance operational efficiency to regain investor confidence.
Balance Sheet Strength and Financial Ratios
Kanoria Chemicals’ balance sheet reflects a challenging financial position, with total borrowings amounting to ₹595 Cr against reserves of ₹499 Cr. This results in a debt-to-equity ratio of 0.84, which is relatively high and indicates a reliance on debt financing. The current ratio stood at 1.11, suggesting adequate liquidity to cover short-term obligations, while the quick ratio of 0.54 indicates potential liquidity issues, as it fails to cover current liabilities without relying on inventory. The company reported a book value per share of ₹141.33, which is significantly higher than its current market price, suggesting that the stock may be undervalued. However, the return on net worth was negative at -6.38% for FY 2024, highlighting the adverse impact of accumulated losses on shareholder equity. The enterprise value (EV) to net operating revenue ratio of 0.65 suggests that the company is trading at a relatively low valuation compared to its revenue, which may attract potential investors looking for value opportunities.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Kanoria Chemicals indicates a strong promoter backing, with promoters holding 74.39% of the total shares. This demonstrates a significant level of control over the company, which can be both a strength and a potential risk. Institutional interest remains minimal, with foreign institutional investors (FIIs) holding only 0.06% and domestic institutional investors (DIIs) at 0.08%. Public shareholding accounted for 25.47%, reflecting a limited retail investor presence. The number of shareholders has increased to 17,824, indicating growing interest at the retail level despite the company’s financial struggles. The consistency in promoter holding over the reporting periods suggests a commitment to the company’s long-term vision, but the lack of institutional support could raise concerns regarding governance and strategic direction. Enhanced transparency and improved financial performance may be necessary to boost investor confidence and attract institutional investments.
Outlook, Risks, and Final Insight
If margins sustain improvement and operational efficiencies are realized, Kanoria Chemicals could potentially reverse its current trend of losses. The ongoing challenges in profitability, coupled with high debt levels, pose significant risks that need to be addressed. The company’s ability to manage costs effectively while improving top-line growth will be crucial in stabilizing its financial position. Additionally, fluctuations in raw material prices and market demand could impact profitability further. If the company can enhance its product offerings and improve its market positioning, it may attract greater investor interest, leading to a more favorable market perception. Strengthening liquidity and reducing reliance on debt financing will also be essential for long-term sustainability. A focused approach on operational enhancements, alongside better cost management strategies, could pave the way for a more resilient financial performance in the future.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Kanoria Chemicals & Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Aeonx Digital Technology Ltd | 91.4 Cr. | 199 | 323/121 | 23.2 | 112 | 0.50 % | 9.78 % | 6.79 % | 10.0 |
| Kanoria Chemicals & Industries Ltd | 347 Cr. | 79.4 | 140/73.0 | 119 | 0.00 % | 2.33 % | 11.8 % | 5.00 | |
| India Glycols Ltd | 6,060 Cr. | 979 | 1,070/502 | 24.9 | 364 | 0.51 % | 12.4 % | 11.1 % | 5.00 |
| Industry Average | 3,203.50 Cr | 419.13 | 24.05 | 198.33 | 0.34% | 8.17% | 9.90% | 6.67 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 386 | 362 | 385 | 445 | 401 | 371 | 342 | 361 | 384 | 374 | 348 | 431 | 454 |
| Expenses | 360 | 356 | 369 | 422 | 391 | 365 | 339 | 333 | 382 | 361 | 348 | 414 | 437 |
| Operating Profit | 27 | 6 | 17 | 23 | 10 | 6 | 3 | 29 | 2 | 13 | -0 | 17 | 16 |
| OPM % | 7% | 2% | 4% | 5% | 3% | 2% | 1% | 8% | 0% | 3% | -0% | 4% | 4% |
| Other Income | 7 | -0 | 3 | -0 | 13 | -0 | 8 | 0 | 2 | 5 | 1 | -27 | 1 |
| Interest | 7 | 8 | 10 | 11 | 11 | 12 | 9 | 12 | 11 | 12 | 11 | 12 | 11 |
| Depreciation | 14 | 14 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 16 | 16 | 17 |
| Profit before tax | 12 | -17 | -5 | -3 | -2 | -21 | -13 | 2 | -22 | -9 | -27 | -38 | -10 |
| Tax % | 30% | -1% | -14% | -70% | 67% | -3% | 14% | 816% | 4% | 76% | 6% | 5% | 32% |
| Net Profit | 9 | -17 | -4 | -1 | -4 | -21 | -15 | -16 | -23 | -16 | -29 | -40 | -14 |
| EPS in Rs | 1.89 | -3.26 | -0.29 | -0.35 | -0.60 | -4.20 | -1.86 | -2.12 | -3.81 | -3.18 | -3.82 | -8.33 | -1.79 |
Last Updated: August 20, 2025, 8:20 am
Below is a detailed analysis of the quarterly data for Kanoria Chemicals & Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 454.00 Cr.. The value appears strong and on an upward trend. It has increased from 431.00 Cr. (Mar 2025) to 454.00 Cr., marking an increase of 23.00 Cr..
- For Expenses, as of Jun 2025, the value is 437.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 414.00 Cr. (Mar 2025) to 437.00 Cr., marking an increase of 23.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 1.00 Cr..
- For OPM %, as of Jun 2025, the value is 4.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00%.
- For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from -27.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 28.00 Cr..
- For Interest, as of Jun 2025, the value is 11.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -10.00 Cr.. The value appears strong and on an upward trend. It has increased from -38.00 Cr. (Mar 2025) to -10.00 Cr., marking an increase of 28.00 Cr..
- For Tax %, as of Jun 2025, the value is 32.00%. The value appears to be increasing, which may not be favorable. It has increased from 5.00% (Mar 2025) to 32.00%, marking an increase of 27.00%.
- For Net Profit, as of Jun 2025, the value is -14.00 Cr.. The value appears strong and on an upward trend. It has increased from -40.00 Cr. (Mar 2025) to -14.00 Cr., marking an increase of 26.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.79. The value appears strong and on an upward trend. It has increased from -8.33 (Mar 2025) to -1.79, marking an increase of 6.54.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:01 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 541 | 531 | 565 | 702 | 837 | 1,072 | 1,005 | 1,095 | 1,369 | 1,578 | 1,475 | 1,537 | 1,606 |
| Expenses | 500 | 506 | 533 | 675 | 802 | 1,008 | 977 | 1,001 | 1,301 | 1,506 | 1,423 | 1,505 | 1,560 |
| Operating Profit | 41 | 25 | 32 | 27 | 35 | 64 | 28 | 94 | 68 | 72 | 52 | 31 | 46 |
| OPM % | 8% | 5% | 6% | 4% | 4% | 6% | 3% | 9% | 5% | 5% | 4% | 2% | 3% |
| Other Income | 43 | 27 | 15 | 7 | 45 | 7 | 22 | 8 | 29 | 10 | 16 | -19 | -21 |
| Interest | 17 | 9 | 14 | 20 | 24 | 36 | 37 | 32 | 27 | 36 | 43 | 46 | 46 |
| Depreciation | 24 | 30 | 34 | 45 | 47 | 49 | 56 | 58 | 57 | 59 | 59 | 63 | 64 |
| Profit before tax | 43 | 13 | -1 | -32 | 10 | -15 | -43 | 11 | 13 | -12 | -34 | -96 | -85 |
| Tax % | 20% | 7% | 414% | -25% | -20% | 30% | -26% | -40% | 83% | 5% | 61% | 12% | |
| Net Profit | 34 | 12 | -7 | -24 | 12 | -20 | -32 | 16 | 2 | -13 | -55 | -108 | -99 |
| EPS in Rs | 7.72 | 2.82 | -1.65 | -3.38 | 3.22 | -3.42 | -5.90 | 3.32 | 1.56 | -2.01 | -8.79 | -19.13 | -17.12 |
| Dividend Payout % | 19% | 53% | -91% | -44% | 47% | -22% | 0% | 0% | 64% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -64.71% | -158.33% | -242.86% | 150.00% | -266.67% | -60.00% | 150.00% | -87.50% | -750.00% | -323.08% | -96.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | -93.63% | -84.52% | 392.86% | -416.67% | 206.67% | 210.00% | -237.50% | -662.50% | 426.92% | 226.71% |
Kanoria Chemicals & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 4% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 16% |
| 3 Years: | -20% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -3% |
| 3 Years: | -7% |
| Last Year: | -11% |
Last Updated: September 5, 2025, 8:50 am
Balance Sheet
Last Updated: October 10, 2025, 2:22 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 474 | 472 | 581 | 558 | 566 | 577 | 547 | 565 | 577 | 584 | 579 | 499 |
| Borrowings | 161 | 331 | 430 | 408 | 440 | 509 | 539 | 493 | 475 | 510 | 509 | 595 |
| Other Liabilities | 152 | 157 | 192 | 222 | 250 | 293 | 266 | 282 | 329 | 366 | 380 | 382 |
| Total Liabilities | 810 | 982 | 1,225 | 1,209 | 1,278 | 1,401 | 1,374 | 1,362 | 1,403 | 1,481 | 1,490 | 1,498 |
| Fixed Assets | 328 | 344 | 512 | 743 | 800 | 850 | 894 | 864 | 863 | 882 | 850 | 865 |
| CWIP | 14 | 182 | 269 | 27 | 12 | 42 | 15 | 14 | 10 | 10 | 47 | 46 |
| Investments | 211 | 174 | 138 | 100 | 63 | 48 | 26 | 19 | 22 | 17 | 16 | 14 |
| Other Assets | 257 | 282 | 306 | 340 | 403 | 461 | 439 | 465 | 507 | 573 | 578 | 574 |
| Total Assets | 810 | 982 | 1,225 | 1,209 | 1,278 | 1,401 | 1,374 | 1,362 | 1,403 | 1,481 | 1,490 | 1,498 |
Below is a detailed analysis of the balance sheet data for Kanoria Chemicals & Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 22.00 Cr..
- For Reserves, as of Mar 2025, the value is 499.00 Cr.. The value appears to be declining and may need further review. It has decreased from 579.00 Cr. (Mar 2024) to 499.00 Cr., marking a decrease of 80.00 Cr..
- For Borrowings, as of Mar 2025, the value is 595.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 509.00 Cr. (Mar 2024) to 595.00 Cr., marking an increase of 86.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 382.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 380.00 Cr. (Mar 2024) to 382.00 Cr., marking an increase of 2.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,498.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,490.00 Cr. (Mar 2024) to 1,498.00 Cr., marking an increase of 8.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 865.00 Cr.. The value appears strong and on an upward trend. It has increased from 850.00 Cr. (Mar 2024) to 865.00 Cr., marking an increase of 15.00 Cr..
- For CWIP, as of Mar 2025, the value is 46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Mar 2024) to 46.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Mar 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2024) to 14.00 Cr., marking a decrease of 2.00 Cr..
- For Other Assets, as of Mar 2025, the value is 574.00 Cr.. The value appears to be declining and may need further review. It has decreased from 578.00 Cr. (Mar 2024) to 574.00 Cr., marking a decrease of 4.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,498.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,490.00 Cr. (Mar 2024) to 1,498.00 Cr., marking an increase of 8.00 Cr..
However, the Borrowings (595.00 Cr.) are higher than the Reserves (499.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -120.00 | -306.00 | -398.00 | -381.00 | -405.00 | -445.00 | -511.00 | -399.00 | -407.00 | -438.00 | -457.00 | -564.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 51 | 57 | 59 | 60 | 50 | 52 | 68 | 46 | 45 | 46 | 56 |
| Inventory Days | 101 | 82 | 86 | 87 | 92 | 96 | 97 | 84 | 97 | 91 | 104 | 84 |
| Days Payable | 77 | 66 | 53 | 77 | 84 | 74 | 85 | 77 | 80 | 75 | 82 | 78 |
| Cash Conversion Cycle | 82 | 68 | 89 | 69 | 68 | 71 | 64 | 75 | 63 | 61 | 68 | 63 |
| Working Capital Days | 43 | -7 | -8 | -5 | -8 | -2 | -7 | 16 | 17 | 8 | 9 | -4 |
| ROCE % | 5% | 1% | 1% | 1% | 3% | 2% | -1% | 4% | 4% | 1% | 1% | -2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
| Diluted EPS (Rs.) | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
| Cash EPS (Rs.) | -10.42 | 1.65 | 10.54 | 13.60 | 16.94 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 119.19 | 141.33 | 138.93 | 137.75 | 136.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 119.19 | 141.33 | 138.93 | 137.75 | 136.25 |
| Revenue From Operations / Share (Rs.) | 351.67 | 337.94 | 361.21 | 313.31 | 250.55 |
| PBDIT / Share (Rs.) | 9.29 | 16.47 | 18.92 | 22.20 | 24.16 |
| PBIT / Share (Rs.) | -5.04 | 2.17 | 5.44 | 9.11 | 10.88 |
| PBT / Share (Rs.) | -22.26 | -8.23 | -2.79 | 3.01 | 2.61 |
| Net Profit / Share (Rs.) | -24.75 | -12.65 | -2.95 | 0.51 | 3.66 |
| NP After MI And SOA / Share (Rs.) | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
| PBDIT Margin (%) | 2.64 | 4.87 | 5.23 | 7.08 | 9.64 |
| PBIT Margin (%) | -1.43 | 0.64 | 1.50 | 2.90 | 4.34 |
| PBT Margin (%) | -6.32 | -2.43 | -0.77 | 0.95 | 1.04 |
| Net Profit Margin (%) | -7.03 | -3.74 | -0.81 | 0.16 | 1.46 |
| NP After MI And SOA Margin (%) | -5.43 | -2.60 | -0.55 | 0.49 | 1.32 |
| Return on Networth / Equity (%) | -16.05 | -6.38 | -1.44 | 1.14 | 2.47 |
| Return on Capital Employeed (%) | -2.37 | 0.96 | 2.44 | 4.00 | 4.81 |
| Return On Assets (%) | -5.57 | -2.57 | -0.59 | 0.48 | 1.06 |
| Long Term Debt / Equity (X) | 0.65 | 0.49 | 0.52 | 0.57 | 0.58 |
| Total Debt / Equity (X) | 1.14 | 0.84 | 0.83 | 0.78 | 0.78 |
| Asset Turnover Ratio (%) | 1.03 | 0.99 | 1.09 | 0.57 | 0.34 |
| Current Ratio (X) | 0.99 | 1.11 | 1.12 | 1.24 | 1.22 |
| Quick Ratio (X) | 0.56 | 0.54 | 0.57 | 0.61 | 0.77 |
| Inventory Turnover Ratio (X) | 5.79 | 3.51 | 4.30 | 4.34 | 2.28 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | -49.84 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 8.70 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 149.84 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 91.30 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.88 | 1.67 | 2.30 | 3.64 | 3.27 |
| Interest Coverage Ratio (Post Tax) (X) | -0.73 | -0.22 | 0.64 | 1.08 | 1.61 |
| Enterprise Value (Cr.) | 900.35 | 972.38 | 951.81 | 1045.87 | 835.26 |
| EV / Net Operating Revenue (X) | 0.58 | 0.65 | 0.60 | 0.76 | 0.76 |
| EV / EBITDA (X) | 22.19 | 13.51 | 11.51 | 10.78 | 7.91 |
| MarketCap / Net Operating Revenue (X) | 0.21 | 0.31 | 0.29 | 0.43 | 0.36 |
| Retention Ratios (%) | 0.00 | 0.00 | 149.84 | 0.00 | 0.00 |
| Price / BV (X) | 0.62 | 0.76 | 0.76 | 0.99 | 0.67 |
| Price / Net Operating Revenue (X) | 0.21 | 0.31 | 0.29 | 0.43 | 0.36 |
| EarningsYield | -0.25 | -0.08 | -0.01 | 0.01 | 0.03 |
After reviewing the key financial ratios for Kanoria Chemicals & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -19.13. This value is below the healthy minimum of 5. It has decreased from -8.79 (Mar 24) to -19.13, marking a decrease of 10.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is -19.13. This value is below the healthy minimum of 5. It has decreased from -8.79 (Mar 24) to -19.13, marking a decrease of 10.34.
- For Cash EPS (Rs.), as of Mar 25, the value is -10.42. This value is below the healthy minimum of 3. It has decreased from 1.65 (Mar 24) to -10.42, marking a decrease of 12.07.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.19. It has decreased from 141.33 (Mar 24) to 119.19, marking a decrease of 22.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.19. It has decreased from 141.33 (Mar 24) to 119.19, marking a decrease of 22.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 351.67. It has increased from 337.94 (Mar 24) to 351.67, marking an increase of 13.73.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 9.29. This value is within the healthy range. It has decreased from 16.47 (Mar 24) to 9.29, marking a decrease of 7.18.
- For PBIT / Share (Rs.), as of Mar 25, the value is -5.04. This value is below the healthy minimum of 0. It has decreased from 2.17 (Mar 24) to -5.04, marking a decrease of 7.21.
- For PBT / Share (Rs.), as of Mar 25, the value is -22.26. This value is below the healthy minimum of 0. It has decreased from -8.23 (Mar 24) to -22.26, marking a decrease of 14.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -24.75. This value is below the healthy minimum of 2. It has decreased from -12.65 (Mar 24) to -24.75, marking a decrease of 12.10.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -19.13. This value is below the healthy minimum of 2. It has decreased from -8.79 (Mar 24) to -19.13, marking a decrease of 10.34.
- For PBDIT Margin (%), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 10. It has decreased from 4.87 (Mar 24) to 2.64, marking a decrease of 2.23.
- For PBIT Margin (%), as of Mar 25, the value is -1.43. This value is below the healthy minimum of 10. It has decreased from 0.64 (Mar 24) to -1.43, marking a decrease of 2.07.
- For PBT Margin (%), as of Mar 25, the value is -6.32. This value is below the healthy minimum of 10. It has decreased from -2.43 (Mar 24) to -6.32, marking a decrease of 3.89.
- For Net Profit Margin (%), as of Mar 25, the value is -7.03. This value is below the healthy minimum of 5. It has decreased from -3.74 (Mar 24) to -7.03, marking a decrease of 3.29.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -5.43. This value is below the healthy minimum of 8. It has decreased from -2.60 (Mar 24) to -5.43, marking a decrease of 2.83.
- For Return on Networth / Equity (%), as of Mar 25, the value is -16.05. This value is below the healthy minimum of 15. It has decreased from -6.38 (Mar 24) to -16.05, marking a decrease of 9.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.37. This value is below the healthy minimum of 10. It has decreased from 0.96 (Mar 24) to -2.37, marking a decrease of 3.33.
- For Return On Assets (%), as of Mar 25, the value is -5.57. This value is below the healthy minimum of 5. It has decreased from -2.57 (Mar 24) to -5.57, marking a decrease of 3.00.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has increased from 0.49 (Mar 24) to 0.65, marking an increase of 0.16.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.14. This value exceeds the healthy maximum of 1. It has increased from 0.84 (Mar 24) to 1.14, marking an increase of 0.30.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.03. It has increased from 0.99 (Mar 24) to 1.03, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1.5. It has decreased from 1.11 (Mar 24) to 0.99, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.56, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.79. This value is within the healthy range. It has increased from 3.51 (Mar 24) to 5.79, marking an increase of 2.28.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 3. It has decreased from 1.67 (Mar 24) to 0.88, marking a decrease of 0.79.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.73. This value is below the healthy minimum of 3. It has decreased from -0.22 (Mar 24) to -0.73, marking a decrease of 0.51.
- For Enterprise Value (Cr.), as of Mar 25, the value is 900.35. It has decreased from 972.38 (Mar 24) to 900.35, marking a decrease of 72.03.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 24) to 0.58, marking a decrease of 0.07.
- For EV / EBITDA (X), as of Mar 25, the value is 22.19. This value exceeds the healthy maximum of 15. It has increased from 13.51 (Mar 24) to 22.19, marking an increase of 8.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has decreased from 0.31 (Mar 24) to 0.21, marking a decrease of 0.10.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 24) to 0.62, marking a decrease of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has decreased from 0.31 (Mar 24) to 0.21, marking a decrease of 0.10.
- For EarningsYield, as of Mar 25, the value is -0.25. This value is below the healthy minimum of 5. It has decreased from -0.08 (Mar 24) to -0.25, marking a decrease of 0.17.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kanoria Chemicals & Industries Ltd:
- Net Profit Margin: -7.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.37% (Industry Average ROCE: 8.17%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -16.05% (Industry Average ROE: 9.9%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.73
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 24.05)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.14
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.03%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Alcohol Based | KCI Plaza, 6th Floor, Kolkata West Bengal 700019 | info@kanoriachem.com http://www.kanoriachem.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. R V Kanoria | Chairman & Managing Director |
| Mr. S V Kanoria | Whole Time Director |
| Mr. H K Khaitan | Non Exe.Non Ind.Director |
| Mrs. Madhuvanti Kanoria | Non Exe.Non Ind.Director |
| Mr. Sidharth Kumar Birla | Ind. Non-Executive Director |
| Mrs. Suhana Murshed | Ind. Non-Executive Director |
| Mrs. Meeta Makhan | Ind. Non-Executive Director |
| Mr. Sumanta Chaudhuri | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Kanoria Chemicals & Industries Ltd?
Kanoria Chemicals & Industries Ltd's intrinsic value (as of 18 October 2025) is 171.87 which is 116.46% higher the current market price of 79.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 347 Cr. market cap, FY2025-2026 high/low of 140/73.0, reserves of ₹499 Cr, and liabilities of 1,498 Cr.
What is the Market Cap of Kanoria Chemicals & Industries Ltd?
The Market Cap of Kanoria Chemicals & Industries Ltd is 347 Cr..
What is the current Stock Price of Kanoria Chemicals & Industries Ltd as on 18 October 2025?
The current stock price of Kanoria Chemicals & Industries Ltd as on 18 October 2025 is 79.4.
What is the High / Low of Kanoria Chemicals & Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kanoria Chemicals & Industries Ltd stocks is 140/73.0.
What is the Stock P/E of Kanoria Chemicals & Industries Ltd?
The Stock P/E of Kanoria Chemicals & Industries Ltd is .
What is the Book Value of Kanoria Chemicals & Industries Ltd?
The Book Value of Kanoria Chemicals & Industries Ltd is 119.
What is the Dividend Yield of Kanoria Chemicals & Industries Ltd?
The Dividend Yield of Kanoria Chemicals & Industries Ltd is 0.00 %.
What is the ROCE of Kanoria Chemicals & Industries Ltd?
The ROCE of Kanoria Chemicals & Industries Ltd is 2.33 %.
What is the ROE of Kanoria Chemicals & Industries Ltd?
The ROE of Kanoria Chemicals & Industries Ltd is 11.8 %.
What is the Face Value of Kanoria Chemicals & Industries Ltd?
The Face Value of Kanoria Chemicals & Industries Ltd is 5.00.